Navigation Links
Sensus Healthcare Announces its Exhibitor Attendance at the 45th ACMS Annual Meeting
Date:4/30/2013

BOCA RATON, Fla., April 30, 2013 /PRNewswire/ -- Sensus Healthcare is proud to announce their exhibitor participation in the 45th American College of Mohs Surgery in Washington, D.C. on May 2-5, 2013. Visit booth #310 to learn more about the advanced SRT-100™ superficial radiotherapy platform, featuring SharpBeam™. The SRT-100 offers unique features and benefits providing Dermatologists with a cost effective, non-invasive option for treating their patients who are diagnosed with skin cancer!

(Logo: http://photos.prnewswire.com/prnh/20130222/FL64841LOGO)

We cordially invite all ACMS attendees to visit our booth (#310) at the upcoming 45th ACMS Annual Meeting in Washington, D.C. and rediscover superficial radiotherapy (SRT). We are proud to feature our SRT-100™; non-invasive treatment system and demonstrate the impact it can have on your practice by providing your patients with a non-invasive treatment option while at the same time increasing your productivity and realizing an excellent ROI! "Superficial Radiotherapy (SRT) is a cost effective alternative to surgery while having the same cure rates. Having SRT in your practice provides the Mohs Surgeon with a Total Solutions approach to treating NMSC," stated Joe Sardano , President/CEO, Sensus Healthcare.     

See you in Washington!

About Sensus Healthcare:   
Sensus Healthcare is the worldwide leader dedicated to Superficial Radiotherapy Technology (SRT). The featured SRT-100 System is the most advanced non-invasive technology used by Dermatologists and Radiation Oncologists throughout the world in treating Basal Cell (BCC) and Squamous Cell (SCC) Carcinomas. The SRT-100 features SharpBeam technology providing
'/>"/>

SOURCE Sensus Healthcare
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Sensus Healthcare Announces Health Canada Approval
2. Sensus Healthcare and Texas Dermatology Associates at Baylor University Medical Center Announce the Formation of the SRT University™ Comprehensive Education Series for Practitioners, Healthcare Professionals, and Patients
3. Anterios, Inc. CEO And Founder, Jon Edelson, To Present At Needham & Companys 12th Annual Healthcare Conference
4. NewLink Genetics to Present at the Needham and Company 12th Annual Healthcare Conference
5. Lexicon To Present At The Needham Healthcare Conference
6. Cempra, Inc. to Present at 12th Annual Needham Healthcare Conference
7. KaloBios to Present at Needham Healthcare Conference
8. Neurocrine Biosciences to Present at the Needham 12th Annual Healthcare Conference
9. Treatment Adherence Emerging as Critical Theme in Improving Quality and Cost of US Healthcare
10. B. Braun Committed to Protecting Healthcare Workers from Exposure to Hazardous Drugs
11. Rutgers Business School and the Blanche and Irwin Lerner Center will explore trends and issues facing the biopharmaceutical industry at a healthcare symposium, Tuesday, April 30
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... OTTAWA , Dec. 24, 2014 /CNW/ - ... Superburn" is being recalled after Health Canada tests confirmed ... serious health risks (beta-methylphenethylamine and phenylpropylmethylamine). The distributor, Empire ... is recalling the product from retail stores across ... body building purposes, including for weight loss and increased ...
(Date:12/24/2014)... Dec. 24, 2014  Novastem, a leader in ... patient in its study for ischemic stroke at ... Association, ischemic strokes account for 87 percent of ... patients in the study, entitled "Internal Research Protocol ... Mesenchymal Stem Cells and Intrathecal Administration of Neural ...
(Date:12/24/2014)...  Actavis plc (NYSE: ACT ) ... complete response letter from the U.S. Food and ... (NDA) for the fixed-dose combination (FDC) of nebivolol ... Photo - http://photos.prnewswire.com/prnh/20130124/NY47381LOGO ... of a complete response letter, Actavis remains committed ...
Breaking Medicine Technology:"Jetfuel Superburn" recalled after Health Canada tests find undeclared drug ingredients 2Novastem Treats First Patient Using Stemedica's Mesenchymal and Neural Stem Cell Combination Therapy for Ischemic Stroke 2Novastem Treats First Patient Using Stemedica's Mesenchymal and Neural Stem Cell Combination Therapy for Ischemic Stroke 3Novastem Treats First Patient Using Stemedica's Mesenchymal and Neural Stem Cell Combination Therapy for Ischemic Stroke 4Actavis Confirms Complete Response Letter for Nebivolol/Valsartan Fixed-Dose Combination for Hypertension 2Actavis Confirms Complete Response Letter for Nebivolol/Valsartan Fixed-Dose Combination for Hypertension 3Actavis Confirms Complete Response Letter for Nebivolol/Valsartan Fixed-Dose Combination for Hypertension 4
... , NEW YORK, ... research report is available in its catalogue: , ... Analysis , http://www.reportlinker.com/p0164271/Multiple-Myeloma-Therapeutics---US-Market-Trends--Analysis.html , Given ... push to develop efficient therapies and treatments to battle ...
... LAS ANGELES, December 2 Fountain Healthy ... programme of,regular updates to shareholders, keeping them informed of the ... business plan, as,well as to provide shareholders with regular updates ... , Fountain reports that it continues ...
Cached Medicine Technology:Reportlinker Adds Multiple Myeloma Therapeutics - US Market Trends & Analysis 2Reportlinker Adds Multiple Myeloma Therapeutics - US Market Trends & Analysis 3Reportlinker Adds Multiple Myeloma Therapeutics - US Market Trends & Analysis 4Reportlinker Adds Multiple Myeloma Therapeutics - US Market Trends & Analysis 5Reportlinker Adds Multiple Myeloma Therapeutics - US Market Trends & Analysis 6Fountain Healthy Aging Inc Business Update For Shareholders 2Fountain Healthy Aging Inc Business Update For Shareholders 3
(Date:12/25/2014)... The report “TS-1 (Colorectal Cancer) – Forecast ... treatment landscape, unmet needs, current pipeline and commercial opportunities ... drug which is typically used for treating colorectal cancer. ... treating gastric cancer and pancreatic cancer. TS-1 is composed ... first approved in 1999 in Japan for the treatment ...
(Date:12/25/2014)... New York (PRWEB) December 25, 2014 ... 2010 DePuy ASR hip recall ( http://www.consumerinjurylawyers.com/DePuy/ ) continue ... reports. According to an Order issued in the U.S. ... the Court will convene an open conference on January ... and United States Courthouse in West Palm Beach, Florida. ...
(Date:12/25/2014)... “Every three months the trends for evening dresses ... will be one of the hottest styles in the next ... the company releases 26 A-line sweetheart evening dresses, and announces ... , “We are trying our best to help a lady ... Along with affordable prices, we provide discounted delivery costs to ...
(Date:12/25/2014)... (PRWEB) December 26, 2014 Recently, iFitDress.com, the ... for women, has announced its new selection of black ... are on sale now; they are available at discounted prices, ... says, “The promotion will last for three weeks only. You ... market. Those who are interested in our new items can ...
(Date:12/25/2014)... December 26, 2014 Recently, Dylan Queen, ... has excitedly released its collection of discounted prom dresses, ... Percy, a senior spokesman of the company, the promotion ... this promotion is to expand the UK market. , ... several different colors, lengths, and styles: A-line strapless, empire ...
Breaking Medicine News(10 mins):Health News:TS-1 Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 2Health News:TS-1 Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 3Health News:Federal Court Overseeing DePuy ASR Hip Lawsuit Set to Convene Conference in January, Bernstein Liebhard LLP Reports 2Health News:Federal Court Overseeing DePuy ASR Hip Lawsuit Set to Convene Conference in January, Bernstein Liebhard LLP Reports 3Health News:iFitDress.com: Black One-Shoulder Cocktail Dresses for 2015 2Health News:Dylan Queen: Cheap Prom Dresses for the UK Market 2
... there are plenty of ways to look and feel younger through ... homework before jumping into a more permanent change. , ... ... priorities to today,s changed economy doesn,t necessarily mean going without. However, ...
... OBS Medical has entered into an agreement ... of medical malpractice for US hospitals, for Beazley ... to hospitals that implement OBS,s Visensia(R) patient monitoring ... by Frost and Sullivan as a 2008 North ...
... March 25 ULURU Inc. (NYSE Alternext: ULU) ... discuss the fourth quarter and year ended 2008 financial results ... 2009 at 10:00 a.m. Eastern Time.To participate in the conference ... 429-1388 (access code 9304#) five to ten minutes prior to ...
... Persons who purchased or paid for (in whole or in ... reimbursed for (in whole or in part) Paxil CR(R) in ... relief as part of a $28 million Proposed Settlement. The ... between April 1, 2002 and March 4, 2005 contained a ...
... part of long-term relationships, , , WEDNESDAY, March 25 (HealthDay ... in long-term relationships transition from a passionate romance to ... isn,t true. , Reporting in the March issue of ... that while the manic, obsessive feelings that come with ...
... March 25 An amazing medical discovery that provides ... is in the US and looking to make the ... Release, go to: http://www.prnewswire.com/mnr/bathmateus/37601/ Developed by engineers, originally ... US at www.bathmateus.com , the Bathmate Hydropump reverses ...
Cached Medicine News:Health News:Orange County Plastic Surgeon Warns: When It Comes To The Face And Body, The Best Deal Could Cost More 2Health News:OBS Medical's Visensia Patient Monitoring Technology Lowers Cost of Medical Malpractice Insurance 2Health News:ULURU Inc. Announces Conference Call to Discuss Financial Results for the Fourth Quarter and Year Ended December 31, 2008 and to Provide a Business Update 2Health News:Proposed Settlement Will Make Up to $28 Million Available to Individuals Who Purchased and Companies That Reimbursed for Paxil CR(R) 2Health News:Romantic Love Can Last 2Health News:Romantic Love Can Last 3Health News:Video: Bathmate Hydropump Poised to Replace Cialis, Levitra, and Viagra 2
Angled for easy insertion into side port incision for manipulation of nucleus. Flat, paddle like tip for placement in groove to crack the nucleus for emulsification....
Excellent during IOL insertion while pushing the trailing haptic into position. Gently curved shaft and round handle....
Angled shaft with 1.5 mm tip designed to efficiently perform the "Stop and Chop" technique. Round knurled handle. Most popular size or model....
Smaller than the kuglen hook, this manipulator offers excellent grasping or lifting of the nucleus. Blunt finger-like 0.5 mm two-prong tip. Round knurled handle with dull finish. Angled....
Medicine Products: